HBM (Lux) Funds - HBM Global Biotechnology Fund A Fonds
463,01
USD
+2,39
USD
+0,52
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Regeneron Pharmaceuticals Inc | US75886F1075 | 6,20% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 5,53% |
| Amgen Inc | US0311621009 | 5,53% |
| argenx SE | NL0010832176 | 5,16% |
| Zealand Pharma A/S | DK0060257814 | 5,04% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 4,78% |
| Blueprint Medicines Corp | US09627Y1091 | 4,24% |
| Gilead Sciences Inc | US3755581036 | 4,05% |
| Insmed Inc | US4576693075 | 3,95% |
| Merus NV | NL0011606264 | 3,49% |
| Sonstige | 52,04% |